Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
19
datasets available to search
ShareScore release 0.9.0
Dataset results
19 results for “STRIVE”
Saxenda in Obesity Services (STRIVE Study)
ClinicalTrials.gov study NCT03036800. IPD Sharing: NO. Countries: 2. Publications: 2.
STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)
ClinicalTrials.gov study NCT02378753. IPD Sharing: Not stated. Countries: 1. Publications: 13.
The STRIVE Before Surgery Pilot Trial
ClinicalTrials.gov study NCT06042491. IPD Sharing: YES. Countries: 1. Publications: 1.
The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types
ClinicalTrials.gov study NCT03085888. IPD Sharing: NO. Countries: 1. Publications: 1.
Striving Towards EmPowerment and Medication Adherence (STEP-AD)
ClinicalTrials.gov study NCT02764853. IPD Sharing: NO. Countries: 1. Publications: 5.
Study to Reduce Intravenous Exposures (STRIVE)
ClinicalTrials.gov study NCT00391482. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Striving to Quit: First Breath
ClinicalTrials.gov study NCT01569490. IPD Sharing: Not stated. Countries: 1. Publications: 1.
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study - supplementary data
<p><b>Objective:</b> To assess efficacy and tolerability of 1-year erenumab treatment in patients with episodic migraine. </p> <p><b>Methods: </b>Patients were randomized (<i>n</i>=955; 1:1:1) during the 24-week double-blind treatment phase (DBTP) to monthly subcutaneous placebo, erenumab 70 or 140mg. At Week 24, 845 patients were re-randomized (1:1) to erenumab 70 or 140mg during the 28-week dose-blinded active-treatment phase (ATP). Monthly migraine days (MMD), achieving ≥50%, ≥75% and 100% reduction in MMD, and safety/tolerability were assessed. </p> <p><b>Results: </b>Mean MMD at DBTP baseline was 8.3. At Week 52, mean changes (SE) from pre-DBTP baseline/Week 24 (pre-ATP baseline) in MMD were −4.2 (0.2)/−1.1 (0.2) (70mg) and −4.6 (0.2)/−1.8 (0.2) (140mg) irrespective of treatment during the DBTP. For patients reducing dose from 140 (DBTP) to 70mg (ATP), change in MMD from Week 24 to 52 was −0.1 (0.3), and for those increasing from 70 (DBTP) to 140mg (ATP) was −1.8 (0.3). At Week 52, 61.0%, 38.5% and 19.8% of patients on erenumab 70mg, and 64.9%, 40.8% and 21.2% on erenumab 140mg, achieved ≥50%, ≥75% and 100% reduction in MMD from DBTP baseline, respectively. Among erenumab-treated patients in DBTP who showed ≥50% reduction in MMD during the last 3 months of DBTP and completed ATP, 86% showed sustained responses at ≥50% during the last 3 months of ATP. Safety of erenumab in the ATP was similar to the DBTP; exposure-adjusted incidence rates of adverse events were similar for either dose.</p> <p><b>Conclusion: </b>Over 52 weeks, erenumab provided sustained efficacy in episodic migraine; the safety profiles were similar between erenumab dose groups in the presence of dose blinding. </p>
The STRIVE Before Surgery Trial
ClinicalTrials.gov study NCT06511258. IPD Sharing: YES. Countries: 1. Publications: 0.
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study - supplementary data
Open the record for dataset details and reuse information.
Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
ClinicalTrials.gov study NCT05605093. IPD Sharing: Not stated. Countries: 24. Publications: 0.
STRIVE - Resilience Curriculum for Novice Physicians-In-Training
ClinicalTrials.gov study NCT05724420. IPD Sharing: NO. Countries: 1. Publications: 0.
Strive Cardio for Endometrial Cancer Survivors
ClinicalTrials.gov study NCT06534008. IPD Sharing: NO. Countries: 1. Publications: 0.
Striving Towards EmPowerment and Medication Adherence R01
ClinicalTrials.gov study NCT06463886. IPD Sharing: NO. Countries: 1. Publications: 0.
Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial
ClinicalTrials.gov study NCT05822583. IPD Sharing: Not stated. Countries: 19. Publications: 0.
STRIVE Post-Market Registry Study
ClinicalTrials.gov study NCT04302272. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Striving to be Strong: Self-management
ClinicalTrials.gov study NCT03405103. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Striving to Quit-Wisconsin Tobacco Quit Line
ClinicalTrials.gov study NCT01569477. IPD Sharing: YES. Countries: 0. Publications: 0.
STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1
ClinicalTrials.gov study NCT07038915. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.